STOCK TITAN

Opus Genetics: Cormorant reports 6.61% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

For Opus Genetics, Inc. common stock, Cormorant Asset Management, LP and Bihua Chen reported beneficial ownership of 5,500,000 shares, or 6.61%. Each reported shared voting and shared dispositive power over the same 5,500,000 shares, which are directly held by certain Cormorant Funds.

Beneficial ownership (each reporting person) 5,500,000 shares Cormorant Asset Management, LP and Bihua Chen each reported this amount; the shares are directly held by certain Cormorant Funds.
Percentage of class 6.61% Reported by each reporting person.
Shared voting power 5,500,000 shares Reported by each reporting person.
Shared dispositive power 5,500,000 shares Reported by each reporting person.
Shares outstanding 83,195,823 shares Opus Genetics common stock outstanding as of August 3, 2026; cited as the basis for the reported percentages.
beneficial ownership regulatory
"Amount beneficially owned: 5,500,000"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared voting power 5,500,000"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power 5,500,000"
Rule 13d-1(k) regulatory
"Joint Filing Statement pursuant to Rule 13d-1(k)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IRD shares did Cormorant Asset Management and Bihua Chen report?

They each reported beneficial ownership of 5,500,000 Opus Genetics shares, or 6.61%, with shared voting and dispositive power over that same block.

Which fund has rights to dividends or sale proceeds from the reported IRD shares?

Cormorant Global Healthcare Master Fund, LP has the right to receive or direct dividends or proceeds from the sale of more than 5% of the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





67577R102

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Cormorant Asset Management, LP
Signature:/s/ Bihua Chen
Name/Title:Bihua Chen, Managing Member
Date:11/16/2026
Bihua Chen
Signature:/s/ Bihua Chen
Name/Title:Bihua Chen
Date:11/16/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on SCHEDULE 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning her or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that she or it knows or has reason to believe that such information is inaccurate. Dated: November 16, 2026 Cormorant Asset Management, LP By: Cormorant Asset Management GP, LLC its General Partner By: /s/ Bihua Chen Bihua Chen, Managing Member Bihua Chen By: /s/ Bihua Chen Bihua Chen

Keep reading